Chemotherapy uses anticancer medicines to destroy cancer cells or reduce their ability to multiply. It may be recommended for selected solid tumours before surgery, after surgery or as treatment for advanced cancer, depending on the diagnosis and treatment goals.
Chemotherapy may be used to treat certain leukaemias, lymphomas and other haematological malignancies. The medicines and treatment schedules depend on the specific cancer, disease stage, patient health and response to therapy.
Immunotherapy uses medicines that help the immune system recognize or respond to cancer. Certain immune checkpoint inhibitors and other treatments may be considered for eligible cancers based on clinical and molecular characteristics.
Targeted therapy uses medicines directed at specific molecular features involved in cancer growth. Molecular testing may help determine whether a tumour has characteristics that make targeted treatment appropriate.
Breast cancer treatment may include chemotherapy, hormonal therapy, targeted treatment or immunotherapy. Medical oncology treatment is selected according to tumour stage, hormone receptor status, HER2 status and other clinical factors.
Lung cancer treatment depends on the tumour type, stage and molecular characteristics. Systemic medical treatment may include chemotherapy, targeted medicines or immunotherapy, sometimes combined with surgery or radiation therapy.
Colorectal cancer affects the colon or rectum. Medical treatment may involve chemotherapy, targeted therapy or immunotherapy for selected patients, depending on tumour stage, molecular findings and the overall treatment plan.
Hormonal therapy for prostate cancer reduces the action or production of hormones that stimulate cancer growth. It may be used alone or alongside other treatments depending on the stage and characteristics of the disease.
Lymphoma is a group of cancers affecting lymphocytes, a type of white blood cell. Treatment may involve chemotherapy, immunotherapy, targeted medicines or other specialized approaches based on the lymphoma subtype.
Leukaemia affects blood-forming tissues and can alter normal blood cell production. Treatment varies significantly by subtype and may include chemotherapy, targeted medicines, immunotherapy and other specialist interventions.
Multiple myeloma is a cancer of plasma cells that can affect the bones, kidneys and blood cell production. Treatment may include combinations of targeted medicines, immunomodulatory therapies, corticosteroids and other approaches.
Melanoma is a cancer arising from pigment-producing cells. Systemic treatment for certain advanced cases may involve immunotherapy or targeted medicines, depending on the tumour's molecular features and stage.
Bone marrow aspiration and biopsy collect samples from the marrow for laboratory examination. They may help investigate certain blood disorders, leukaemia, lymphoma or abnormalities in blood cell production.
A peripherally inserted central catheter provides longer-term access to a central vein. It may be used for certain chemotherapy regimens, supportive medicines or other treatments requiring reliable intravenous access.